Need Help? Call 1­-866-­796-­7386
« back to stock screener

  MYGN stock: Myriad Genetics, Inc.

Current Rating
Strong Sell

Previous Rating:

Buy
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$16.99
Market Cap
1.16B
Sector
Health Care
Div. Growth
-
P/E
13.0
P/B
1.6
P/S
1.57
Dividend %
-
P/CF
-
P/FCF
12.1
Op. Cash Flow
108.7K
FCF
1.4
Op. Margin
17.30%
Net Margin
13.00%
ROE
12.90%
ROI
16.50%
ROA
10.00%
EPS Growth
-12.20%
Current Ratio
4.3
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Navidea Biopharmaceuticals Inc (NAVB) $0.73 - - 137.2M Strong Buy
Community Health Systems (CYH) $5.72 - - 617.3M Strong Buy
AngioDynamics, Inc. (ANGO) $17.11 - - 627.7M Strong Buy
Juniper Pharmaceuticals Inc (JNP) $5.45 - - 60.7M Strong Buy
CRYO-CELL International, Inc. (CCEL) $4.10 - - 29.6M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More